Reid S. McCarthy's most recent trade in Annovis Bio Inc was a trade of 2,000 Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 2.95 per share. | 10 Jun 2025 | 2,000 | 9,305 (0%) | 0% | 3.0 | 5,900 | Common Stock |
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2023 | 29,600 | 29,600 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 12.61 per share. | 07 Apr 2023 | 476 | 7,305 (0%) | 0% | 12.6 | 6,002 | Common Stock |
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 5,967 | 5,967 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Annovis Bio Inc | Reid S. McCarthy | Director | Purchase of securities on an exchange or from another person at price $ 37.61 per share. | 19 Aug 2021 | 500 | 6,829 (0%) | 0% | 37.6 | 18,805 | Common Stock, $0.0001 par value |
| Annovis Bio Inc | Reid S. McCarthy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 4,000 | 4,000 | - | - | Stock Option (right to buy) |